ANIP - ANI Pharmaceuticals to cease operations at Oakville Canada manufacturing plant
ANI Pharmaceuticals (NASDAQ:ANIP) on Thursday said it plans to stop operations at its Oakville, Canada manufacturing plant by Q1 2023. The biopharmaceutical company said it would move most of the products made or packaged in Oakville to one of its three U.S. sites. ANIP believes this action will improve profitability and cash flow by $7M-$8M on an annualized basis. ANI said it will look for potential buyers for the Oakville site. ANIP stock earlier closed -3.3% at $29.51.
For further details see:
ANI Pharmaceuticals to cease operations at Oakville, Canada manufacturing plant